BRIEF published on 10/30/2025 at 21:05, 1 month 16 days ago TME Pharma's Semi-Annual Report and Financial Restructuring Financial Results Biotechnology CEO Appointment Bond Issuance TME Pharma
PRESS RELEASE published on 10/30/2025 at 21:00, 1 month 16 days ago TME Pharma publishes its semi annual results and half-year report TME Pharma publishes semi annual results and half-year report showing cost reductions, new CEO, and fundraising activities. Focus on NOX-A12 and NOX-E36 assets Fundraising Cost Reductions TME Pharma NOX-A12 Semi Annual Results
PRESS RELEASE published on 09/01/2025 at 08:45, 3 months 15 days ago Inside Information: Other news releases TME Pharma completes August financing, with €500k cash received on August 28th, bringing cash position to €2.35M. Organization aims to attract financing for cancer and eye therapies Cash Position TME Pharma August Financing Cost-efficient Organization Novel Therapies
BRIEF published on 09/01/2025 at 08:45, 3 months 15 days ago TME Pharma successfully completes its August fundraising round Biotechnology Fundraising Treasury Cryptocurrencies Cancer
BRIEF published on 08/25/2025 at 08:05, 3 months 22 days ago TME Pharma Secures €500,000 through New Bond Issue Investment Strategy Cost Reduction Bond Issuance Financial Strategy Shareholder Commitments
PRESS RELEASE published on 08/25/2025 at 08:00, 3 months 22 days ago Inside Information / Other news releases TME Pharma to raise €500k through bond issue & receives new shareholding notice. CEO & Chairman also invest. Funds to boost financial position & support R&D projects & investment strategy Fundraising Shareholding CEO Bond Issue TME Pharma
BRIEF published on 07/08/2025 at 08:05, 5 months 8 days ago TME Pharma Terminates Liquidity Contract Amid Cost Optimization Liquidity Contract Biotechnology Refinancing Cost Optimization TME Pharma
PRESS RELEASE published on 07/08/2025 at 08:00, 5 months 8 days ago Inside Information / Other news releases TME Pharma terminates liquidity contract with Invest Securities to optimize costs. Improve trading volume of shares and healthy liquidity deemed contract unnecessary. Finds success in refinancing and reducing operational costs Liquidity Contract Cost Optimization Trading Volume Organizational Restructuring TME Pharma
BRIEF published on 05/21/2025 at 08:05, 6 months 26 days ago TME Pharma Enhances Financial Outlook with €1.7M Bond Commitments Strategic Partnerships Bond Issuance Clinical Programs Financial Visibility Cost Structure
PRESS RELEASE published on 05/21/2025 at 08:00, 6 months 26 days ago Inside Information / Other news releases TME Pharma extends financial visibility to May 2026 by securing €1.7M financing through regular bonds with attached warrants. CEO and board show strong commitment to company's success Clinical Programs TME Pharma Financial Visibility Regular Bonds Private Warrants
Published on 12/16/2025 at 19:25, 51 minutes ago Cypher Metaverse Inc. Announces Signing of Definitive Agreement for Acquisition
Published on 12/16/2025 at 18:00, 2 hours 16 minutes ago RTO SPA Terminated: Mumena Mushinge, Brian Chasala, Terra Metals Inc. and Terra Metals Limited Failed to Provide Necessary Due Diligence Information and Failed to File CSE Application
Published on 12/16/2025 at 14:30, 5 hours 46 minutes ago Worksport Launches Rivian R1T Pickup Truck Compatible Cover, SOLIS Solar Tonneau
Published on 12/16/2025 at 14:00, 6 hours 16 minutes ago QNX Embedded Technology Now Powering More Than 275 Million Vehicles on the Road
Published on 12/16/2025 at 14:00, 6 hours 16 minutes ago Loop Industries and Ester Industries' India Joint Venture Awards Detailed Engineering Contract to Toyo for Infinite Loop(TM) India
Published on 12/16/2025 at 18:30, 1 hour 46 minutes ago SIX Exchange Regulation approves delisting of u-blox registered shares and grants exemption from specific disclosure requirements
Published on 12/16/2025 at 17:32, 2 hours 43 minutes ago M&G Credit Income Investment Trust plc: Net Asset Value(s)
Published on 12/16/2025 at 18:53, 1 hour 22 minutes ago Number of shares and voting rights - November 2025 (In French only)
Published on 12/16/2025 at 18:10, 2 hours 5 minutes ago Amundi crosses the statutory threshold of 2% upwards
Published on 12/16/2025 at 17:45, 2 hours 31 minutes ago Imerys-December-2025-information-share-capital-and-voting-rights-as-of-30-November-2025
Published on 12/16/2025 at 17:43, 2 hours 33 minutes ago Aéroports de Paris S.A - November 2025 traffic figures
Published on 12/16/2025 at 08:30, 11 hours 46 minutes ago Cie du Bois Sauvage: Buy back of own shares – week from 08/12/2025 to 12/12/2025
